DaShenLin Pharmaceutical Group Co., Ltd. Price (603233.SS)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

1,132,522,507

(0.3152)%

Table Charts
Bar Charts

Revenue and Profitability

Year 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Revenue 3,252,460,226 3,706,656,074 4,545,011,007 5,265,481,859 6,273,722,022 7,421,196,903 8,859,273,708 11,141,165,082 14,582,865,282 16,759,335,264 21,248,086,692 24,531,390,152
Net Income 149,183,213 197,382,181 265,501,554 395,434,058 430,188,669 474,960,964 531,633,897 702,661,961 1,062,181,101 791,230,980 1,035,723,834 1,166,498,182
FCF USD 229,457,394 -75,773,123 186,763,036 220,751,021 188,247,354 -28,144,663 319,245,136 1,206,363,362 1,161,593,290 260,049,045 2,721,786,682 1,377,206,988
OCF USD 289,310,273 288,219,956 448,578,297 468,587,221 495,601,186 640,388,127 873,639,844 1,707,770,707 1,953,915,828 1,554,994,863 3,756,573,435 3,173,848,330

Financial Health - DEBT

Year 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
YTPD 0.00 0.05 0.31 0.19 0.07 0.00 0.04 0.37 3.49 5.23 3.94 4.04
D/E 0.38 0.55 1.02 0.25 0.31 0.19 0.12 0.08 0.26 0.96 0.95 0.80
CA/CL 1.31 1.10 1.01 1.18 1.10 1.35 1.18 1.37 1.52 1.10 1.10 0.94
TA/TL 1.62 1.54 1.32 1.62 1.60 1.93 1.89 2.00 1.82 1.52 1.49 1.49
Total Debt 126,195,188 290,000,000 510,003,502 260,336,769 409,177,300 515,179,150 352,827,286 329,286,690 1,399,184,368 5,275,103,024 5,931,133,677 5,440,904,134

Management Performance

Year 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
ROIC 33.45% 25.12% 33.19% 32.19% 24.71% 14.30% 15.19% 14.68% 15.37% 7.77% 9.16% 9.19%
ROE 45.45% 37.55% 53.08% 38.72% 32.65% 17.25% 17.50% 16.57% 19.73% 14.44% 16.67% 17.09%
ROA 0.00% 11.74% 13.04% 15.88% 11.97% 8.15% 8.04% 8.03% 8.78% 4.64% 5.18% 4.84%
NM % 4.59% 5.33% 5.84% 7.51% 6.86% 6.40% 6.00% 6.31% 7.28% 4.72% 4.87% 4.76%
FCF / R% 0.00% -2.04% 4.11% 4.19% 3.00% -0.38% 3.60% 10.83% 7.97% 1.55% 12.81% 5.61%
FCF / NI% 153.81% -38.39% 60.57% 52.28% 43.92% -5.93% 60.73% 173.19% 107.26% 32.33% 252.19% 118.06%
Operating Margin (OM) 0.00 0.07 0.04 0.11 0.13 0.18 0.17 0.18 0.18 0.16 0.15 0.15

Per Share

Year 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
EPS 0.29 0.27 0.36 0.46 0.44 0.47 0.49 0.63 0.94 0.70 0.91 1.03
SPS 6.43 5.09 6.22 6.08 6.44 7.30 8.22 9.96 12.87 14.76 18.70 21.66
OCPS 0.57 0.40 0.61 0.54 0.51 0.63 0.81 1.53 1.72 1.37 3.31 2.80
FCPS 0.45 -0.10 0.26 0.25 0.19 -0.03 0.30 1.08 1.03 0.23 2.40 1.22
BVPS 0.75 0.81 0.79 1.18 1.38 2.76 2.86 3.87 4.92 5.23 6.04 7.00

Per Share - CAGR

Year 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
CAGR-EPS 0.29 0.27 0.36 0.46 0.44 0.47 0.49 0.63 0.94 0.70 0.91 1.03
CAGR-SPS 6.43 5.09 6.22 6.08 6.44 7.30 8.22 9.96 12.87 14.76 18.70 21.66
CAGR-OCPS 0.57 0.40 0.61 0.54 0.51 0.63 0.81 1.53 1.72 1.37 3.31 2.80
CAGR-FCPS 0.45 -0.10 0.26 0.25 0.19 -0.03 0.30 1.08 1.03 0.23 2.40 1.22
CAGR-BVPS 0.75 0.81 0.79 1.18 1.38 2.76 2.86 3.87 4.92 5.23 6.04 7.00
Revenue $24.53B
3Y
5Y
7Y
10Y
Net Income $1.17B
3Y
5Y
7Y
10Y
Operating Cash Flow $3.17B
3Y
5Y
7Y
10Y
Free Cash Flow $1.38B
3Y
5Y
7Y
10Y
YTPD $4.04
3Y
5Y
7Y
10Y
D/E $0.80
3Y
5Y
7Y
10Y
CA/CL $0.94
3Y
5Y
7Y
10Y
TA/TL $1.49
3Y
5Y
7Y
10Y
ROIC $9.19%
3Y
5Y
7Y
10Y
ROE $17.09%
3Y
5Y
7Y
10Y
ROA $4.84%
3Y
5Y
7Y
10Y
Net Margin $4.76%
3Y
5Y
7Y
10Y
FCF / R% $5.61%
3Y
5Y
7Y
10Y
FCFNI % $118.06%
3Y
5Y
7Y
10Y
Operating Margin $0.15
3Y
5Y
7Y
10Y
EPS $1.03
3Y
5Y
7Y
10Y
SPS $21.66
3Y
5Y
7Y
10Y
OCPS $2.80
3Y
5Y
7Y
10Y
FCPS $1.22
3Y
5Y
7Y
10Y
BVPS $7.00
3Y
5Y
7Y
10Y
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation